Literature DB >> 17949525

Prostate weight: an independent predictor for positive surgical margins during robotic-assisted laparoscopic radical prostatectomy.

Lambda P Msezane1, Ofer N Gofrit, Shang Lin, Arieh L Shalhav, Gregory P Zagaja, Kevin C Zorn.   

Abstract

INTRODUCTION: Pre-operative prediction of pathological stage represents the cornerstone of prostate cancer management. Patient counseling is routinely based on pre-operative PSA, Gleason score and clinical stage. In this study, we evaluated whether prostate weight (PW) is an independent predictor of extracapsular extension (ECE) and positive surgical margin (PSM).
METHODS: Between February 2003 and November 2006, 709 men underwent robotic-assisted laparoscopic radical prostatectomy (RLRP). Pre-operative parameters (patient age, pre-operative PSA, biopsy Gleason score, clinical stage) as well as pathological data (prostate weight, pathological stage) were prospectively gathered after internal-review board (IRB) approval. Evaluation of the influence of these variables on ECE and PSM outcomes were assessed using both univariate and multivariate logistic regression analysis.
RESULTS: Mean overall patient age, pre-operative PSA and PW were 59.6 years, 6.5 ng/ml and 52.9 g (range 5.5 g-198.7 g), respectively. Of the 393, 209 and 107 men with PW < 50 g, 50 g-< 70 g and < 70 g, ECE was observed in 20.1%, 15.3% and 9.3%, respectively (p = 0.015). In the same patient cohorts, PSM was observed in 25.4%, 14.4% and 7.5%, respectively (p < 0.001). In a multivariate logistic regression analysis, PW, in addition to pre-operative PSA, biopsy Gleason score and clinical stage, was an independent risk factor for ECE (p < 0.001). Similarly, in multi-variate analysis, PW was observed to be a risk factor for PSM (p < 0.001).
CONCLUSIONS: PW is an independent predictor of both ECE and PSM, with an inverse relationship having been demonstrated between both variables. PW should be considered when counseling patients with prostate cancer treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17949525

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  6 in total

1.  Impact of a preoperatively estimated prostate volume using transrectal ultrasonography on surgical and oncological outcomes in a single surgeon's experience with robot-assisted radical prostatectomy.

Authors:  Yosuke Hirasawa; Yoshio Ohno; Jun Nakashima; Kenji Shimodaira; Takeshi Hashimoto; Tatsuo Gondo; Makoto Ohori; Masaaki Tachibana; Kunihiko Yoshioka
Journal:  Surg Endosc       Date:  2015-11-17       Impact factor: 4.584

2.  Effects of robotic-assisted laparoscopic prostatectomy on surgical pathology specimens.

Authors:  Heng Hong; Lin Mel; Jonathan Taylor; Qiang Wu; Hugh Reeves
Journal:  Diagn Pathol       Date:  2012-03-13       Impact factor: 2.644

3.  Robotic Prostatectomy Has a Superior Outcome in Larger Prostates and PSA Density Is a Strong Predictor of Biochemical Recurrence.

Authors:  S Bishara; N Vasdev; T Lane; G Boustead; J Adshead
Journal:  Prostate Cancer       Date:  2014-12-15

4.  Combined Systematic and MRI-US Fusion Prostate Biopsy Has the Highest Grading Accuracy When Compared to Final Pathology.

Authors:  Iulia Andras; Emanuel Darius Cata; Andreea Serban; Pierre Kadula; Teodora Telecan; Maximilian Buzoianu; Maria Bungardean; Dan Vasile Stanca; Ioan Coman; Nicolae Crisan
Journal:  Medicina (Kaunas)       Date:  2021-05-22       Impact factor: 2.430

5.  Impact of prostate size on pathologic outcomes and prognosis after radical prostatectomy.

Authors:  Sun Ho Min; Yong Hyun Park; Seung Bae Lee; Ja Hyeon Ku; Cheol Kwak; Hyeon Hoe Kim
Journal:  Korean J Urol       Date:  2012-07-19

6.  Does size matter? The significance of prostate size on pathologic and functional outcomes in patients undergoing robotic prostatectomy.

Authors:  Carl A Olsson; Hugh J Lavery; Dov Sebrow; Ardavan Akhavan; Adam W Levinson; Jonathan S Brajtbord; John Carlucci; Paul Muntner; David B Samadi
Journal:  Arab J Urol       Date:  2011-11-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.